cystic fibrosis transmembrane conductance regulator; epithelial sodium channel; trafficking CYSTIC FIBROSIS (CF) is a systemic disorder that results from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) and is the most common severely lifeshortening autosomal recessive genetic disease in Caucasians. CFTR is a cAMP-regulated channel that carries chloride and other anions and is critically involved in the regulation of epithelial surface fluid composition. Absence of CFTR leads to altered salt and water transport by CFTR-expressing epithelia resulting in abnormally viscous secretions that can obstruct the lumen into which they are secreted in a number of organs, including those of the respiratory, gastrointestinal, and reproductive tracts. The obstruction of airways in the lung predisposes to chronic respiratory infections, inflammation, bronchiectasis, and eventually respiratory failure.
In addition to its function as a chloride and anion channel, CFTR regulates epithelial ion transport by other apical membrane ion transporters. For example, CFTR apparently modulates ATP secretion (3) , where the ATP then acts in an autocrine fashion via purinergic receptors to stimulate chloride transport (53) . CFTR also appears critical in regulating bicarbonate transport (34) . This likely has a significant role in the regulation of epithelial fluid pH at many sites as well as in the pancreatic and digestive abnormalities of CF (11) .
Perhaps the most studied regulatory interaction of CFTR is its interaction with the epithelial sodium channel (ENaC), which is increasingly recognized to have a vital role in the function of pulmonary epithelia. ENaC and CFTR are colocalized at the apical surface of epithelia and have functional interactions that may be tissue specific. In the airways, the presence and/or activation of CFTR is associated with inhibition of ENaC activity, whereas in the sweat duct, activation of CFTR increases ENaC-mediated sodium transport (26, 30, 36, 48, 56) . ENaC functional expression appears increased in CF compared with non-CF airway epithelia. In vivo, this is inferred from greater polarization of the CF transepithelial nasal potential and greater depolarization of the nasal potential on addition of amiloride, a specific blocker of ENaC. After the application of amiloride, the transepithelial nasal potential of subjects with and without CF is similar (32) . This dysregulated hyperactivity of ENaC in the CF airway likely leads to enhanced absorption of water from the airway surface liquid (39) . In vitro (39) and ex vivo (1, 62) , this correlates with decreased ciliary propulsion of mucus and may lead to compromised clearance of bacteria from the CF airway.
The mechanisms by which CFTR and ENaC interact, and by which ENaC has increased activity in the CF airway, are unclear and remains controversial even though such functional interactions are observed in both epithelial and nonepithelial cells (4, 8, 25, 30, 31, 48, 56, 58) . Like in respiratory epithelia, in many models, activation of CFTR is generally associated with inhibition of ENaC (22, 25, 31, 33, 56, 58) . This inhibition may reflect a decrease in ENaC open probability (P o ) (57) , which, in turn, may reflect decreased activation of ENaC by proteolysis of its extracellular loops when CFTR is present and active (40) .
In Xenopus oocytes, ENaC-mediated Na ϩ transport is decreased in the presence of wild-type (wt) CFTR. Activation of CFTR further decreases rat or murine ENaC-mediated current in oocytes (30, 31, 33, 58) . Others have suggested that this additional decrease in ENaC-mediated current on CFTR activation may result from a series resistor error (42, 43) and have presented data suggesting that activation of CFTR in oocytes does not result in a further decrease in human ENaC (hENaC)-mediated current (42) . We (58, 67) confirmed that activation of wt CFTR does not further decrease hENaC-mediated current in oocytes but observed that coexpression of wt CFTR decreased the functional expression of ENaC in oocytes even before activation of CFTR. We also showed that the magnitude of decrease in ENaC-mediated Na ϩ transport in the presence of wt CFTR (without CFTR activation) corresponded to decreased expression of ENaC at the oocyte surface (67) . These data suggested that wt CFTR alters the trafficking of ENaC in oocytes.
⌬F508 is a temperature-sensitive trafficking mutant of CFTR (16) and is the most prevalent mutation found in North American Caucasian patients with CF. In contrast to wt CFTR, ⌬F508 does not inhibit the functional expression of ENaC in oocytes either without or with CFTR activation (38, 58) . These data suggest a lack of trafficking interactions between ⌬F508 and ENaC in oocytes. It remains an open question as to whether correction of ⌬F508 trafficking and function will also restore appropriate regulation of ENaC trafficking and function.
Together, these data support the hypothesis that the presence of CFTR affects ENaC trafficking and surface expression. The studies presented here test this hypothesis in the CFBE41o Ϫ model of CF airway epithelia (2) and further test the hypothesis that corrected ⌬F508 will appropriately regulate ENaC trafficking and function. Our data agree with our previous findings in oocytes (67) and suggest that wt CFTR decreases the whole cell, functional, and apical surface expression of endogenous hENaC in these cells, which supports the hypothesis that wt CFTR alters ENaC trafficking. In contrast, ⌬F508, as well as "trafficking-corrected ⌬F508," appears to lack these trafficking interactions with endogenous hENaC, which contradicts our hypothesis and suggests that additional measures may be required to effect full functionality of pharmacologically repaired ⌬F508 in the CF airway.
MATERIALS AND METHODS

Cell culture. Immortalized CFBE41o
Ϫ CF bronchial epithelial cells (parental, CFTR genotype ⌬F508/⌬F508) and derivative cell lines that stably overexpress wt (CFBE41o Ϫ wt) or ⌬F508 (CFBE41o Ϫ ⌬F508) CFTR after lentiviral transduction and puromycin selection (2) were a generous gift of Dr. J. P. Clancy (University of Alabama at Birmingham). Cells were routinely cultured at 37°C as previously described (2) . For transepithelial ion transport measurements in Ussing chambers, cells were grown as polarized epithelial monolayers on Snapwells (Costar, Corning Life Sciences, Lowell, MA) and used when transepithelial resistance was Ͼ500 ⍀·cm 2 as assessed by an epithelial voltohmmeter (EVOM; World Precision Instruments, Sarasota, FL). After achieving this resistance, cells were treated without or with 1 M dexamethasone (Dex; Sigma-Aldrich, St. Louis, MO) for 24 h before assay. In some experiments, cells were incubated without or with 1 M hydrocortisone or 1 M aldosterone (Sigma-Aldrich) for 24 h before assay. In other experiments, cells were incubated at 27°C for 48 h before assay to allow improvement of ⌬F508-CFTR trafficking (16 (10, 35) was from Affinity Bioreagents (Golden, CO). Rabbit anti-␥-ENaC (10) was from Abcam (Cambridge, MA). Rabbit anti-serum-and glucocorticoid-induced kinase 1 (SGK1) was from Upstate Biotechnology-Millipore (Billerica, MA). Anti-phosphorylated SGK1 (phospho-Thr256) was from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse anti-GAPDH was from Chemicon-Millipore.
Immunoblot. Cell lysates were prepared in RIPA buffer (150 mM NaCl, 50 mM Tris·HCl, pH 8, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS) containing a protease inhibitor cocktail (1:1,000 dilution; Sigma-Aldrich). Lysates were passed through a 22-gauge needle and cleared by centrifugation (15,000 g, 15 min, 4°C). Protein content was determined with Bio-Rad DC reagents and bovine ␥-globulin as a standard. Equal amounts of protein were resolved by SDS-PAGE and transferred to nitrocellulose as previously described (49, 52) . Nonspecific binding was blocked by incubation with either 3% BSA in TBS (10 mM Tris·HCl, pH 8, 150 mM NaCl) and 0.05% Tween 20 or 5% nonfat milk in TBS/0.05% Tween 20. Primary and horseradish peroxidase (HRP)-conjugated secondary antibodies were applied in TBS, 0.05% Tween-20 with 5% nonfat milk, 3% BSA, or 1% BSA. Immunoreactivity was detected by chemiluminescence (ECL, GE Healthcare-Amersham, Piscataway, NJ, or SuperSignal, Pierce-Thermo Fisher Scientific, Rockford, IL) and fluorography. Densitometry was performed using an Alpha Imager 2200 system (Alpha Innotech, San Leandro, CA) as previously described (50, 52) .
Immunoprecipitation. Cell lysates were prepared in RIPA buffer as described above. Primary antibody was covalently immobilized on beads using the Crosslink Immunoprecipitation Kit (Pierce-Thermo Fisher Scientific) according to the manufacturer's instructions. Precipitated proteins were released by heating in sample buffer, resolved by SDS-PAGE, and specifically detected by immunoblot as described above.
Short-circuit current measurements. Cells grown on filter inserts were mounted in a modified, vertical Ussing chamber, and the monolayers were continuously voltage-clamped to 0 mV after fluid resistance compensation using automatic voltage clamps (VCC-600; Physiologic Instruments, San Diego, CA). Filters were mounted in bath solution (115 mM NaCl, 25 mM NaHCO3, 2.4 mM KH2PO4, 1.2 mM K 2HPO4, 1.2 mM MgCl2, 1.2 mM CaCl2, 10 mM glucose) warmed to 37°C. The solution was pregassed and then continuously gas-lifted with a 95% O2-5% CO2 mixture yielding a pH of 7.3-7.4. The short-circuit current (I sc) was digitized at one sample per 20 s, and data were stored on a computer hard drive using Acquire & Analyze software build 2.2 (Physiologic Instruments). The data acquisition software measured transepithelial resistance automatically by passing a 5-mV, 0.2-s, bipolar pulse across the monolayer and calculating resistance (R) by Ohm's law (v ϭ IR); these resistances remained stable throughout these experiments. A positive deflection in I sc is defined as the net movement of a cation toward the apical bath.
Amiloride and cycloheximide (Sigma-Aldrich) were dissolved as 1,000ϫ stocks in bath solution. Forskolin and IBMX (Sigma-Aldrich) were dissolved as 1,000ϫ stocks in DMSO. The inhibitor CFTRinh-172 (37) was obtained from the CFTR Modulator Library (Dr. Robert Bridges, Rosalind Franklin University, Chicago Medical School) and dissolved as a 1,000ϫ stock in DMSO. In some experiments, apical application of 10 g/ml trypsin (final concentration) was used to activate "near-silent" (low P o) ENaC (7) . In other experiments, a basolateral-to-apical chloride gradient was imposed by replacing the apical bathing solution with a low chloride buffer containing 115 mM sodium gluconate, 25 mM NaHCO3, 2.4 mM KH2PO4, 1.2 mM K2HPO4, 1.2 mM MgCl2, 1.2 mM CaCl2, and 10 mM glucose. This buffer was also pH 7.3-7.4 when gassed with a 95% O2-5% CO2 mixture.
ENaC functional expression was defined as I sc that was inhibited by application of 10 M amiloride to the apical bath in the presence of otherwise identical (symmetric) apical and basolateral bath solutions. CFTR functional expression was determined in the presence of 10 M amiloride and was defined as I sc that was inhibited by apical application of 10 M CFTRinh-172 after treatment of the cells with 10 M forskolin and 100 M IBMX and imposition of the basolateral-toapical chloride gradient.
Statistical analyses. Statistical significance was determined by a two-tailed Student's t-test or a one-way ANOVA as appropriate. All statistical analyses were performed with SigmaStat version 2.03. A P value of Յ0.05 was considered significant.
RESULTS
Dex induces amiloride-sensitive I sc in CFBE41o
Ϫ parental cells. We confirmed that ⌬F508-homozygous CFBE41o Ϫ parental human bronchial epithelial cells form polarized monolayers on permeable supports and have minimal endogenous amiloride-sensitive I sc under usual conditions (2) (Fig. 1A , closed circles, representative Ussing chamber data). Previous data demonstrated that Na ϩ transport in airway epithelia is induced by mineralocorticoids (13) and, especially at the time of birth, glucocorticoids (27, 65) . We therefore tested whether Dex would induce functional expression of amiloride-sensitive I sc in these cells. We inferred that this amiloride-sensitive I sc reflects endogenous ENaC functional expression, as other ion transporters that are present in airway epithelia and inhibited by amiloride, such as Na ϩ -H ϩ exchanger 1 (NHE-1) (18) , are electroneutral and would not be detected in I sc experiments. We observed a significant increase in amiloride-sensitive I sc when these CFBE41o Ϫ parental cells were exposed to 1 M Dex for 24 h (Fig. 1A , open circles, representative data; Fig.  1B , summary data). There was no significant CFTR-mediated I sc (forskolin/IBMX-stimulated, CFTR inh -172-inhibited I sc in the presence of basolateral-to-apical Cl Ϫ gradient) in these ⌬F508-homozygous cells in the absence or presence of Dex (Fig. 1C) .
Dex (Fig. 2 ) that was similar in magnitude to the CFBE41o Ϫ parental cells (Fig. 1B) . In contrast, there was no increase in amiloride-sensitive I sc after Dex treatment in CFBE41o Ϫ wt cells. These data are consistent with the presence of wt CFTR inhibiting ENaC functional expression in this model.
It is important to note that, in this experimental protocol, CFTR was not activated by treatment with forskolin/IBMX before determination of amiloride-sensitive I sc , and these determinations of amiloride-sensitive I sc were performed with identical apical and basolateral bath solutions. Furthermore, baseline I sc was similar among the parental, ⌬F508, and wt cells, and the magnitude of I sc induced by forskolin/IBMX in these cell lines in symmetric bath solutions (in the absence of an imposed basolateral-to-apical Cl Ϫ gradient) was negligible ( Table 1 ). Baseline transepithelial resistances were similar in the ⌬F508 and wt cells and higher in the CFBE41o Ϫ parental cells. Finally, amiloride-sensitive I sc was also negligible in CFBE41o
Ϫ wt cells when 10 M CFTR inh -172 was present at the apical surface for 24 h before and during determination of amiloride-sensitive I sc either without (0.08 Ϯ 0.09 A/cm 2 , n ϭ 13) or with (0.11 Ϯ 0.06 A/cm 2 , n ϭ 12) Dex treatment. These data and considerations support the notion that the lack of amiloride-sensitive I sc in the CFBE41o Ϫ wt cells likely does not result from differences in baseline or stimulated CFTRmediated ion transport or other forskolin/IBMX-stimulated ion transport under these experimental conditions.
After imposition of the basolateral-to-apical Cl Ϫ gradient, as expected, there remained negligible forskolin/IBMX-stimulated, CFTR inh -172-inhibited (CFTR-mediated) I sc in the CFBE41o Ϫ ⌬F508 cells either in the absence (n ϭ 13) or presence of Dex (n ϭ 14, data not shown). In contrast, there was Ϫ60.1 Ϯ 6.0 A/cm 2 CFTR-mediated I sc in the CFBE41o Ϫ wt cells (mean Ϯ SE, n ϭ 9) under control conditions that was not significantly altered by incubation with Dex [Ϫ66.8 Ϯ 4.2 A/cm 2 CFTRmediated I sc , n ϭ 9; P ϭ not significant (ns)]. These data affirm that wt CFTR was present and functional in the CFBE41o Ϫ wt cells.
Dex primarily increases amiloride-sensitive I sc by its action as a glucocorticoid. To address whether Dex stimulates ENaC functional expression in CFBE41o
Ϫ parental and ⌬F508 cells primarily via its glucocorticoid or mineralocorticoid activity, we assessed amiloride-sensitive I sc after treatment with hydrocortisone or aldosterone, respectively. As shown in Fig. 3 , incubation with 1 M hydrocortisone for 24 h caused an increase in amiloride-sensitive I sc in both the CFBE41o Ϫ parental (Fig. 3A ) and ⌬F508 cells (Fig. 3B ) that was similar to that induced by Dex in these cells. In contrast, similar incubation with 1 M aldosterone was ineffective at increasing amiloride-sensitive I sc . We also assessed the influence of Dex treatment on the expression of SGK1 in these cells. SGK1, the expression of which is induced by mineralocorticoids (45) as well as glucocorticoids in airway epithelial cells (27) , can enhance ENaC functional and surface expression by phosphorylating the E3 ubiquitin ligase Nedd4 -2 and decreasing the interaction of Nedd4 -2 with ENaC; this decreases ENaC retrieval from the cell surface (15, 55) . As shown in Fig. 3C (representative immunoblots) and Fig. 3D (densitometry), Dex caused modestly increased SGK1 protein expression in CFBE41o Ϫ parental, ⌬F508, and wt cells, albeit to similar degrees. In contrast, Dex treatment caused increased levels of phosphorylated SGK1, as detected by immunoprecipitation experiments using a phospho-SGK1-specific antibody (Fig.  3E ). These data suggest that CFBE41o Ϫ parental, ⌬F508, and wt cells have similar responsiveness to Dex and that this response is associated with increased phosphorylation of SGK1.
Whole cell expression of endogenous ␣-and ␥-ENaC is reduced when wt CFTR is expressed in CFBE41o
Ϫ cells. We next assessed the whole cell expression of CFTR and of the ␣-and ␥-subunits of ENaC by immunoblot (Fig. 4A , representative immunoblots, Fig. 4B , densitometry of ENaC immunoblots). Higher molecular weight, presumably mature band C CFTR was readily detected in the CFBE41o Ϫ wt cells, and lower molecular weight, presumably immature band B CFTR was detected in the CFBE41o Ϫ ⌬F508 cells. Consistent with previous data (2), CFTR immunoreactivity was not present in the CFBE41o Ϫ parental cells. In response to Dex, CFTR immunoreactivity increased in both the wt-and ⌬F508-overexpressing cells but remained undetectable in the parental Values are presented as means Ϯ SE. Baseline Isc and transepithelial resistance were determined in CFBE41o Ϫ cells as described in MATERIALS AND METHODS after incubation in the absence or presence of 1 M dexamethasone (Dex) for 24 h. After subsequent addition of 10 M amiloride to the apical bath, the change in Isc in response to addition to forskolin/IBMX was determined in otherwise identical apical and basolateral baths. wt, Wild-type. cells. Furthermore, treatment with Dex did not cause detection of higher molecular weight band C CFTR in the ⌬F508-overexpressing cells. These data suggest that Dex increases the whole cell content of wt and ⌬F508 in their respective overexpressing CFBE41o
Ϫ cell lines but that, together with the aforementioned functional data, Dex does not cause an increase in CFTR-mediated current in CFBE41o Ϫ wt cells or improved maturation and function of ⌬F508 in CFBE41o Ϫ ⌬F508 cells.
␣-And ␥-ENaC subunits were readily detected under control conditions in the parental cells with relative mobility consistent with that of the full-length subunits (Fig. 4A) ; similar blots for the ␤-ENaC subunit had significantly less robust signal that limited interpretation (data not shown). We did observe a lower molecular weight form of the ␥-subunit using this COOH-terminally directed anti-␥-ENaC. This form of the ␥-subunit is consistent with that found in proteolytically processed or "cleaved" higher P o ENaC. Such cleavage may occur at the cell surface by the endogenous channel-activating proteases (63, 66) or by exogenous trypsin (7) or elastase (17) or result from action of the trans-Golgi resident endoprotease furin (23) . In contrast, we did not consistently observe a lower molecular weight form of ␣-ENaC consistent with cleaved, higher P o channel using this NH 2 -terminally directed anti-␣-ENaC (data not shown). Dex-treated parental cells had similar abundance of the three subunits compared with control cells (Fig. 4B) .
␣-And ␥-ENaC were also readily detected in the CFBE41o Ϫ ⌬F508-overexpressing cells (Fig. 4A ) with abundances that were similar to the CFBE41o Ϫ parental cells and were again not influenced by exposure to Dex. In contrast, whole cell expression of ␣-and full-length ␥-ENaC subunits was reduced in CFBE41o Ϫ wt-overexpressing cells compared with parental cells, whereas the abundance of the cleaved ␥-subunit in wt-overexpressing cells was similar to the parental and ⌬F508-overexpressing cells (Fig.  4B) . Again, the abundances of ␣-and ␥-ENaC in wt- Fig. 3 . Hydrocortisone mimics the effect of Dex, which modestly induces serum-and glucocorticoid-induced kinase 1 (SGK1) expression. CFBE41o
Ϫ parental (A) or ⌬F508-CFTR-overexpressing (B) cells were grown under control conditions or exposed to 1 M hydrocortisone, aldosterone, or Dex for 24 h before determination of amiloride-sensitive Isc. Data are presented as amiloride-sensitive Isc relative to the mean amiloride-sensitive Isc of Dex-treated cells (means Ϯ SE for n replicates). For C-E, CFBE41o
Ϫ parental, ⌬F508-CFTR-overexpressing, and wt-overexpressing cells were grown in the absence or presence of 1 M Dex for 24 h as described in MATERIALS AND METHODS. C: whole cell lysates were prepared, and immunoblot detection of SGK1, and of GAPDH as a loading control, was performed as described in MATERIALS AND METHODS. Representative immunoblots are shown. Molecular mass is shown in kilodaltons. D: densitometry was performed as described in MATERIALS AND METHODS. Data are presented as the expression of SGK1 in the presence of Dex relative to that in the absence of Dex (means Ϯ SE for the indicated number of independent experiments). Statistical significance was determined by t-test for each cell line, and all had statistically significant increases in SGK1 expression relative to non-Dex-treated cells (P Ͻ 0.05). There was no statistically significant difference in the Dex-induced increase in SGK1 expression among the 3 cell lines [P ϭ not significant (ns) by ANOVA]. E: whole cell lysates were subject to immunoprecipitation (IP) using anti-SGK1 (Parental) or anti-phosphorylated (phospho-, P-) Thr256-SGK1 (⌬F508, WT-CFTR). Precipitated proteins were resolved by SDS-PAGE, and phospho-Thr256-SGK1 (Parental) or total SGK1 (⌬F508 and WT-CFTR) in the precipitates was revealed by immunoblot. Similar results were obtained when the antibodies were used in reverse sequence, and data are representative of 3 experiments for each cell line.
overexpressing cells were not significantly altered by incubation with Dex (Fig. 4B) . We again did not consistently observe a lower molecular weight form of ␣-ENaC indicative of the cleaved channel in the wt-and ⌬F508-overexpressing cells (data not shown). Together, these data are consistent with expression of wt CFTR decreasing the whole cell expression of ␣-and ␥-ENaC in bronchial epithelial cells.
wt CFTR decreases the stimulation of amiloride-sensitive I sc in response to application of trypsin to the apical surface of CFBE41o Ϫ cells. Others have suggested that one mechanism by which ⌬F508-homozygous CF airway epithelia have higher ENaC functional expression is that the CF epithelia may have a higher fraction of cleaved (higher P o ) ENaC at the cell surface than non-CF epithelia (40) . These investigators used trypsin to activate low P o ENaC in Ussing chamber experiments and observed a smaller fractional increase in ENaCmediated (amiloride-sensitive) I sc in ⌬F508 vs. wt CFTRexpressing cells in response to trypsin. These authors further hypothesized that this resulted from increased ENaC cleavage in CF epithelia after its delivery to the cell surface (40) , perhaps by the endogenous channel-activating protease prostasin (41) . However, their data are also consistent with altered trafficking in CF vs. non-CF epithelia and perhaps delivery of a higher amount or proportion of cleaved ENaC to the apical membrane in CF epithelia.
We tested these alternative hypotheses by measuring amiloride-sensitive I sc after application of trypsin to the apical surface of CFBE41o Ϫ parental, ⌬F508, and wt cells. Under control conditions (in the absence of Dex), there was no amiloride-sensitive I sc in the CFBE41o Ϫ parental (n ϭ 13), ⌬F508 (n ϭ 16), or wt (n ϭ 12) cells. This is consistent with both cleaved (higher P o ) and uncleaved (low P o ) ENaC being absent from the apical surface under control conditions without Dex. After treatment with Dex for 24 h and trypsin for 5 min, Ϫ wt CFTR-expressing cells have reduced whole cell abundance of ␣-and ␥-epithelial sodium channel (ENaC). CFBE41o Ϫ parental, wt-overexpressing, and ⌬F508-CFTR-overexpressing cells were grown in the absence or presence of 1 M Dex for 24 h as described in MATERIALS AND METHODS. Whole cell lysates were prepared, and immunoblot detection of CFTR (representative of 3 independent immunoblots), of ␣-and ␥-ENaC, and of GAPDH as a loading control was performed as described in MATERIALS AND METHODS. A: representative immunoblots. There was no other immunoreactivity noted outside of the area of these blots presented. B: densitometry of the ␣-and ␥-ENaC immunoblots was performed as described in MATERIALS AND METHODS. Data are presented as means Ϯ SE, with statistical significance determined by ANOVA as indicated. Number of independent experiments analyzed were: ␣-ENaC, n ϭ 4; ␥-ENaC, n ϭ 4.
both the CFBE41o
Ϫ parental (Ϫ1.36 Ϯ 0.19 A/cm 2 , n ϭ 14) and ⌬F508 (Ϫ1.45 Ϯ 0.16 A/cm 2 , n ϭ 13) cells had increased amiloride-sensitive I sc that was ϳ50% greater than that observed before addition of trypsin ( Fig. 5 ; see also Figs. 1B and 2, respectively). In contrast, CFBE41o
Ϫ wt cells still had negligible amiloride-sensitive I sc (Ϫ0.05 Ϯ 0.03 A/cm 2 , n ϭ 11) after Dex and trypsin treatment (Fig. 5) . These data are consistent with the hypothesis that wt CFTR regulates and decreases the trafficking of both cleaved, higher P o and uncleaved, low P o endogenous ENaC to the apical surface of CFBE41o Ϫ cells. In contrast, endogenous ENaC trafficking in CFBE41o Ϫ cells does not appear to be regulated or influenced by ⌬F508 overexpression.
Correction of ⌬F508 trafficking with 4-phenylbutyrate does not restore CFTR regulation of ENaC functional expression. 4-Phenylbutyrate (4PBA) is a prototype corrector of ⌬F508 trafficking (49) , but recent data suggest that it also increases the trafficking to and functional expression of ENaC the apical surface of nasal epithelial cells (47) . In vivo, both ⌬F508-expressing CF mice (20) and ⌬F508-homozygous humans (51) treated with 4PBA had unaltered ENaC function in their nasal epithelia despite improved ⌬F508 function, suggesting that 4PBA-corrected ⌬F508 may not influence ENaC function in epithelia as does wt CFTR. We tested this hypothesis for endogenous ENaC in CFBE41o
Ϫ parental and ⌬F508 cells by incubation with 1 mM 4PBA for 48 h, with the latter 24 h of this incubation performed in the absence or presence of Dex.
Consistent with previous reports suggesting that expression of ⌬F508 in CFBE41o Ϫ parental cells is negligible (2), there was no CFTR inh -172-inhibited I sc in CFBE41o Ϫ parental cells after 4PBA treatment either in the absence (n ϭ 17) or presence (n ϭ 19) of Dex (data not shown). When cultured in the presence of 4PBA (1 mM, 48 h) but in the absence of Dex, CFBE41o
Ϫ parental cells exhibited minimal amiloride-sensitive I sc (Ϫ0.14 Ϯ 0.06 A/cm 2 , n ϭ 16), suggesting that cleaved, higher P o ENaC was not abundant at the apical surface. In contrast, in the presence of Dex and 4PBA, there was an increase in amiloride-sensitive I sc (Ϫ1.02 Ϯ 0.21 A/cm 2 , n ϭ 19; P ϭ 0.0035) in the parental cells similar in magnitude to that observed in the absence of 4PBA (Fig. 1B) .
In separate experiments, addition of trypsin to the apical surface acutely increased amiloride-sensitive I sc by ϳ50% in 4PBA/Dex-treated cells (Ϫ0.96 Ϯ 0.14 A/cm 2 before vs. Ϫ1.47 Ϯ 0.22 A/cm 2 after trypsin, n ϭ 18; P ϭ 0.0002; Fig. 6A ) but not in parental cells treated with 4PBA alone (Ϫ0.11 Ϯ 0.05 A/cm 2 before vs. Ϫ0.02 Ϯ 0.01 A/cm 2 after trypsin, n ϭ 17; P ϭ ns). These data are consistent with 4PBA not affecting the abundance of uncleaved, low P o ENaC at the apical surface in the absence of Dex as well as not altering the fraction of uncleaved, low P o ENaC at the apical surface in the presence of Dex.
We performed a similar series of experiments in CFBE41o Ϫ ⌬F508-overexpressing cells. In these cells, 4PBA treatment caused modest restoration of CFTR functional expression Ϫ parental, CFBE41o Ϫ ⌬F508, and CFBE41o Ϫ wt cells before and after trypsin treatment of the apical surface. CFBE41o
Ϫ parental, ⌬F508-CFTR-overexpressing, and wt-expressing cells were grown in the presence of 1 M Dex for 24 h, and amiloride-sensitive Isc was determined in Ussing chambers before (gray bars) and after (open bars) 5 min of exposure to 10 g/ml trypsin in the apical bath. Data are presented as means Ϯ SE for n individual experiments, with P value determined by ANOVA.
(Ϫ1.09 Ϯ 0.17 A/cm 2 , n ϭ 13), which was not altered by Dex (Ϫ1.01 Ϯ 0.16 A/cm 2 , n ϭ 13; P ϭ ns; Fig. 6B ). There was again minimal amiloride-sensitive I sc in 4PBA-treated cells in the absence of Dex (Ϫ0.17 Ϯ 0.04 A/cm 2 , n ϭ 13). However, exposure to Dex for the second 24 h of incubation with 4PBA resulted in significantly greater amiloride-sensitive I sc (Ϫ2.96 Ϯ 0.40 A/cm 2 , n ϭ 13; Fig. 6A ) than that observed in both parental cells exposed to 4PBA and Dex (P Ͻ 0.001; Fig. 5A ) and ⌬F508-overexpressing cells exposed to Dex alone (Fig. 2) . These data suggest that the combination of ⌬F508 overexpression and exposure to 4PBA synergistically promotes functional expression of endogenous ENaC in airway cells. These data also provide evidence to contradict the hypothesis that 4PBA-induced correction of ⌬F508-CFTR is sufficient to restore appropriate regulation of ENaC by CFTR in airway epithelia.
We also used trypsin to infer the abundance of uncleaved, low P o ENaC at the apical surface of 4PBA/Dex-treated CFBE41o Ϫ ⌬F508-overexpressing cells (Fig. 6A) . Here, exposure of the apical surface of 4PBA/Dex-treated cells to trypsin caused an additional ϳ1.6-fold increase in amiloride-sensitive I sc (Ϫ4.83 Ϯ 0.78 A/cm 2 , n ϭ 13; P ϭ 0.002), which is a similar fractional increase to that observed in our other experiments. Again, cells exposed to 4PBA without Dex had no significant amiloride-sensitive I sc in response to trypsin (data not shown). Together, these data suggest that repair of ⌬F508 trafficking with 4PBA does not alter the proportion of cleaved, higher P o vs. uncleaved, low P o ENaC at the apical surface of epithelial cells but that overexpressed ⌬F508 and 4PBA may act synergistically to increase the overall abundance of ENaC at the apical surface.
Influence of 4PBA on ENaC retrieval from the apical membrane. To probe the mechanism by which 4PBA synergistically increases ENaC functional expression in CFBE41o Ϫ ⌬F508-overexpressing cells, we determined the apparent firstorder rate constants (k app s) of functional ENaC retrieval from the apical membrane. CFBE41o
Ϫ parental (Fig. 7A ) or CFBE41o Ϫ ⌬F508-overexpressing (Fig. 7B ) cells were incubated in the absence or presence of 1 mM 4PBA for 48 h, with 1 M Dex included in the latter 24 h of incubation. Amiloridesensitive currents were then determined in the presence of cycloheximide to block new channel synthesis, and k app s for decay of amiloride-sensitive currents were determined. In CFBE41o Ϫ parental cells (Fig. 7A) , the k app s for decay of amiloride-sensitive I sc were similar in the absence (k app ϭ Ϫ0.241 Ϯ 0.025 h Ϫ1 , n ϭ 13) vs. presence (k app ϭ Ϫ0.257 Ϯ 0.025 h
Ϫ1
, n ϭ 13; P ϭ ns) of 4PBA. The k app for retrieval of functional ENaC was slightly but not significantly greater in CFBE41o Ϫ ⌬F508-overexpressing cells (k app ϭ Ϫ0.312 Ϯ 0.030 h Ϫ1 , n ϭ 10; Fig. 7B ) vs. CFBE41o Ϫ parental cells without 4PBA (P ϭ ns by ANOVA). In the ⌬F508-overexpressing cells, as in the parental cells, 4PBA did not alter the k app for functional ENaC retrieval (k app ϭ Ϫ0.323 Ϯ 0.016 h
, n ϭ 15; P ϭ ns; Fig. 7B ). These data suggest that 4PBA and overexpression of ⌬F508-CFTR must either synergistically enhance the rate of functional ENaC delivery to the apical membrane or the rate at which ENaC is recycled to the membrane after its retrieval.
Low temperature decreases functional expression of endogenous ENaC. Finally, we tested the influence of an alternate means to correct ⌬F508 trafficking, reduced temperature (16), on endogenous ENaC expression in CFBE41o Ϫ parental and ⌬F508-overexpressing cells (Fig. 8) . As expected, both parental and ⌬F508-overexpressing cells incubated at 27°C for 48 h in control media still lacked ENaC functional expression (Ϫ0.13 Ϯ 0.05 A/cm Fig. 8B ), which is similar to that achieved by 4PBA treatment (Fig. 6B ). Reduced temperature incubation had less effect on parental cells (Ϫ0.37 Ϯ 0.05 A/cm 2 , n ϭ 6; Fig. 8B ). Again, Dex treatment did not Fig. 7 . Influence of 4PBA on ENaC retrieval from the apical membrane in CFBE41o Ϫ parental and ⌬F508-overexpressing cells. CFBE41o Ϫ parental (A) or ⌬F508-overexpressing (B) cells were incubated for 24 h in the absence () or presence (OE) of 1 mM 4PBA for 48 h. In all cases, 1 M Dex was added to the media for the latter 24 h of this incubation. Amiloride-sensitive Isc was determined before and at the indicated times after addition of 100 M cycloheximide to both apical and basolateral baths and are expressed relative to the amiloride-sensitive current before incubation with cycloheximide (means Ϯ SE). Error bars contained within the symbols are not apparent. Apparent first-order rate constants (kapp) were obtained using the Regression Wizard of SigmaPlot 2000 (means Ϯ SE) and compared by a 2-tailed t-test.
significantly alter these CFTR-mediated currents (⌬F508, Ϫ1.47 Ϯ 0.14 A/cm 2 , n ϭ 13; parental, Ϫ0.17 Ϯ 0.08 A/cm 2 , n ϭ 8; Fig. 8B , open bars). One possible interpretation of these data is that in ⌬F508-overexpressing cells, improved ⌬F508 trafficking induced by reduced temperature is sufficient to restore regulation of endogenous ENaC trafficking by ⌬F508. However, our data in the parental cells, where there is only minimal ⌬F508 whole cell abundance (Fig. 4A and Ref.
2) and minimal functional expression after low temperature correction in the presence of Dex (Fig. 8B) , suggest that this interpretation may not be correct. Instead, these data in parental cells may suggest that reduced temperature itself may inhibit Dex-induced functional expression of endogenous ENaC in CFBE41o Ϫ cells regardless of whether CFTR is present.
DISCUSSION
A cardinal feature of CF airways is greater than normal sodium absorption through the ENaC. This ENaC hyperactivity is hypothesized to contribute to CF airways disease by depleting airway surface liquid and thereby decreasing mucociliary clearance of bacteria from the CF airway (3). In fact, genetic overexpression of ENaC in mice creates a CF-like airway phenotype even in the presence of active CFTR (30) . Also in support of this hypothesis, therapies designed to overcome airway surface liquid depletion by osmotic means, such as inhalation of 7% (hypertonic) saline, improve mucociliary clearance (14) and clinical outcome (17) in subjects with CF.
ENaC hyperactivity in the CF airway in vivo is inferred from assessment of transepithelial nasal potentials. The nasal epithelium of subjects with CF is more polarized than that of subjects without CF and demonstrates increased depolarization after topical (apical) application of amiloride than does the nasal epithelium of non-CF subjects (25) . These findings have been replicated in CF and non-CF tracheal and bronchial airways in vivo (14) . In these cases, as well as in significant other literature (Refs. 32 and 40 for examples) and in the present report, amiloride is considered to specifically inhibit ENaC when applied to an apical surface of an epithelium. As such, alteration of the electrical properties of an epithelium (such as inhibition of I sc or change in potential difference) is interpreted as inhibition of ENaC.
However, it is clear that amiloride can also inhibit other ion transporters. Amiloride inhibits the function of NHE, and NHE-1 is present in airway epithelia (18) . However, we do not feel that inhibition of NHE-1 by amiloride confounds our data because NHE-1 is an electroneutral cation exchanger and therefore would be "silent" in the present experiments where we assessed I sc , or net movement of ions.
Amiloride can also inhibit nonselective cation channels. Although the presence of these channels at the apical surface and their inhibition by amiloride (K i ; approximately 50-to 100-fold greater than the K i for ␣␤␥-ENaC) is demonstrated in alveolar epithelia (19, 21, 28, 29) and in H441 cells (Clara cell-like) (5), the presence of these nonselective cation channels in bronchial epithelial cells such as those used in the present study has not been reported. Furthermore, studies using antisense oligonucleotides suggest that the nonselective cation channel is composed exclusively of the ␣-subunit of ENaC, not the ␤-or ␥-ENaC subunits (19, 28, 29) , and the potential effects of extracellular loop proteolysis on nonselective cation channel P o are also not reported. Thus, even if the nonselective cation channel is present in our model system, it is clearly closely related to ENaC, as it comprises ␣-ENaC subunits, is inhibited by amiloride with a greater K i , and transports Na ϩ as well as other cations. Therefore, we feel that the possible presence of nonselective cation channels does not significantly confound our interpretation, and the usual interpretation of others, that the I sc inhibited by apical application of amiloride reflects ENaC-mediated Na ϩ transport. Mechanism of ENaC hyperactivity in CF epithelia. Despite significant previous study, the mechanism by which ENaC becomes hyperactive in the CF airway, or conversely the mechanism by which CFTR limits or regulates ENaC activity in the non-CF airway, remains controversial. Early data suggested that CFTR regulated ENaC P o in heterologous cells (56) , although in other experiments and model systems, ENaC P o appeared quite variable (9) . With more recent data suggesting that proteolytic cleavage of the ␣-and ␥-subunits of ENaC in their luminal/extracellular loops is a major mechanism by which ENaC P o is regulated and that both cleaved (furinprocessed, higher P o ) and uncleaved (near-silent or low P o ) channel can be delivered to the apical membrane of epithelia (24) , such variability in P o may have reflected altered proportions of cleaved (active) and uncleaved (near-silent) channels induced by CFTR.
The literature clearly supports two mechanisms by which total ENaC-mediated current is regulated at the apical surface of epithelia. The surface expression of ENaC, or total number of channels in the membrane, can be regulated at the level of channel delivery/insertion (19), retrieval (15, 54, 55) , and/or recycling to the membrane after retrieval (6) . The P o of the channel is significantly increased by proteolysis of the extracellular loops of the ␣-and ␥-subunits (as described above) as well as acutely in renal cells by phosphoinositide second messengers such as phosphatidylinositol 4,5-biphosphate generated by phospholipase C linked in response to, for example, purinergic signaling (46) .
Recent data support the notion that CF airway epithelia have a higher proportion of cleaved/active (high P o ) ENaC in the apical membrane compared with non-CF airway epithelia (40, 61) . In one of these studies (40), this conclusion was inferred from a greater percent increase in amiloride-inhibited I sc in the non-CF vs. CF airway epithelia on exposure of the apical surface to trypsin; this strategy activates low P o , uncleaved ENaC present at the apical surface. Although these data supported the hypothesis that this increased proportion of cleaved/ active ENaC in CF epithelia results from increased ENaC cleavage by endogenous channel-activating proteases (63, 66) or prostasin (41) after its delivery to the apical membrane (40, 41, 61) , some of these data (40) are also consistent with delivery of a higher proportion of furin-cleaved channel to the apical membrane of CF epithelia. It should be noted that these alternate interpretations are not mutually exclusive.
We also utilized apical application of trypsin to activate low P o , uncleaved ENaC, as did other studies (41, 61) that have addressed aspects of this issue. Neither our experiments nor those of other investigators (41, 61) specifically targeted or evaluated other means of modulating ENaC P o , such as purinergic signaling and phospholipase C activation. Therefore, our interpretation of these data is consistent with that of these other investigators that the acute increase in amiloride-sensitive I sc after apical application of trypsin does allow inference about the amount of uncleaved, low P o ENaC at the apical surface of the epithelia, even in the absence of direct assessment of ENaC P o . This inference is supported by clear demonstration in single-channel studies that trypsin treatment indeed increases ENaC P o (7) .
There has also been significant controversy as to how activation of CFTR by maneuvers that increase intracellular cAMP might contribute to regulation of ENaC. In Xenopus laevis oocytes, a number of groups demonstrated decreased ENaCmediated currents in two-electrode voltage-clamp experiments on forskolin/IBMX stimulation of CFTR-rodent ENaC-coinjected oocytes (30, 31, 38, 58, 68) . However, others suggested that these findings might be an artifact of a series resistor error (42, 43) , in part because such regulation of hENaC was not observed. In addressing this issue in detail, we demonstrated that activation of CFTR acutely decreased the surface expression of murine ENaC but not hENaC in CFTR-ENaC-coinjected oocytes (68) . Our studies here do not further address this important issue as an additional potential site of ENaC regulation by CFTR. In fact, recent data by Van Goor and colleagues (64) suggest that potentiation (or enhancement) of the function of G551D CFTR with the novel small molecule VX-770 decreases amiloride-inhibited transepithelial potential difference in human bronchial epithelial cells within a few minutes. The effect of VX-770 was enhanced (over a slightly longer time frame) by concomitant addition of forskolin and was blocked by CFTR inh -172. These data support the notion that there is also acute regulation of ENaC functional expression by activated CFTR, which may indicate electrical coupling or a requirement for CFTR-mediated anion transport.
ENaC surface expression is influenced by CFTR. Our group's studies of the regulation of ENaC by wt and mutant CFTRs in Xenopus oocytes have suggested that CFTR may also regulate ENaC whole cell and surface expression. Coexpression of CFTRs with appropriate intracellular trafficking [wt (67) and I148T (60)] decrease ENaC functional, surface, and/or whole oocyte expression compared with oocytes expressing ENaC alone in the absence of specific treatments to activate CFTR (i.e., without forskolin/IBMX stimulation). In contrast, coexpression of mutant CFTRs with defective trafficking [⌬F508 (67) and N1303K (59)] did not alter ENaC functional, surface, and/or whole oocyte expression when under similar, nonstimulated conditions.
The experiments here aimed to test the hypothesis that ENaC functional and surface expression in airway epithelial cells is different in the presence of wt vs. ⌬F508-CFTR. Importantly, we studied the influence of CFTR on endogenous hENaC expression in the immortalized CFBE41o
Ϫ model of CF airway epithelia. Under usual conditions, these cells have negligible amiloride-sensitive (ENaC-mediated) I sc (2), a finding we confirmed. However, we were readily able to induce amiloridesensitive I sc , which we infer is functional expression of endogenous ENaC in the parental (⌬F508-homozygous) and ⌬F508-overexpressing cells, by treatment with Dex. This was likely a result of the glucocorticoid rather than mineralocorticoid action of Dex, as hydrocortisone but not aldosterone mimicked the effect of Dex. However, this also occurred without significant change in the whole cell abundance of endogenous ␣-and ␥-ENaC subunits. These data suggest that Dex caused this increase in ENaC functional expression by increasing the surface expression, or altering the trafficking, of channels that were already present in the cell rather than by increasing ␣-ENaC synthesis (12, 44) .
A key finding of these experiments is the Dex treatment failed to induce amiloride-sensitive I sc (ENaC functional expression) in CFBE41o Ϫ cells that express wt CFTR. This occurred in the absence of CFTR activation, as our experimental protocol assessed amiloride-sensitive I sc before activation of CFTR with forskolin/IBMX. As one could hypothesize based on an electrical coupling model that a baseline tonic level of CFTR-mediated ion transport exists in these cells and prevents ENaC functional expression after Dex, we tested whether CFTR blockade with CFTR inh -172 could restore the ability of Dex to induce amiloride-sensitive I sc . However, amiloride-sensitive I sc was again not observed after Dex treatment in the CFBE41o Ϫ wt cells in the presence of CFTR inh -172, which is not consistent with the hypothesis that wt CFTR-mediated ion transport is responsible for the absence of ENaC functional expression in these experiments. Further-more, under conditions that we used to assess amiloridesensitive I sc , namely in symmetric apical and basolateral buffers, there was little stimulation of I sc by forskolin/IBMX in any of these cell lines (parental, ⌬F508, or wt; Table 1 ) before the imposition of a basolateral-to-apical Cl Ϫ gradient. Although the influence of CFTR inhibition with CFTR inh -172 apparently differs between our experiments (no effect on amiloride-sensitive I sc ) and the experiments of Van Goor et al. (64) discussed above where inhibition of VX-770 potentiated G551D CFTR-increased amiloride-sensitive transepithelial potential difference, we do not feel that these data are contradictory. In the experiments of Van Goor et al. (64) , amiloridesensitive transepithelial potential difference (presumably due to ENaC functional expression) was clearly present under control conditions, and the influence of VX-770 occurred within minutes suggesting an effect on ENaC that was already at the apical membrane. In contrast, in the previous characterization of the CFBE41o Ϫ model system (2) and in our experiments, amiloride-sensitive I sc was absent from the apical membrane under control conditions. As discussed above, our data are consistent with Dex increasing the expression of ENaC at the apical surface, an effect that is apparently blocked by expression of wt CFTR. Taken together, we feel that these data are consistent with CFTR regulating ENaC function at two levels, intracellular trafficking and at the apical surface. The suggested regulation of trafficking that results in decreased surface expression is apparently insensitive to inhibition of CFTR by CFTR inh -172 and therefore may not require CFTR activation or CFTR-mediated anion transport. In contrast, the regulation of ENaC by CFTR at the apical surface may be diminished by CFTR inh -172 and therefore suggests a requirement for CFTR-mediated anion transport or electrical coupling.
Interestingly, whole cell abundance of ␣-and uncleaved ␥-ENaC subunits was reduced in the wt CFTR-expressing cells compared with the parental and ⌬F508 cells, with Dex having no significant effect on these abundances. These data are consistent with our (67) previous data regarding the differential influence of wt and ⌬F508 on the whole cell expression of ␤-ENaC in Xenopus oocytes and also support the hypothesis that wt CFTR, but not ⌬F508, modulates ENaC abundance and surface expression and, as a result, reduces its functional expression in airway epithelia.
Myerburg and colleagues (40) hypothesized that the increased amiloride-sensitive I sc in CF vs. non-CF cells might reflect an increased proportion of cleaved, active ENaC at the apical surface of the CF cells due to aberrant protease/antiprotease balance at the apical surface. To address this hypothesis, we attempted activation of near-silent (low P o ) ENaC by apical application of trypsin. Although both the CFBE41o Ϫ parental and ⌬F508-overexpressing cells had ϳ50% greater amiloride-sensitive I sc after trypsin treatment, the CFBE41o Ϫ wt-expressing cells again had little amiloride-sensitive I sc even after trypsin treatment. These data suggested that wt CFTR also prevented uncleaved, low P o endogenous ENaC from residing in the apical membrane in CFBE41o Ϫ cells. These data therefore are not consistent with the hypothesis of Myerburg and colleagues (40) that wt CFTR increases the proportion of uncleaved, low P o ENaC in the apical membrane as its mechanism of decreasing ENaC functional expression in epithelia.
Our data do not directly address the underlying mechanism by which Dex increases ENaC functional expression in CFBE41o Ϫ parental and ⌬F508-overexpressing cells. Our data also do not directly address how wt CFTR prevents the functional and surface expression of ENaC that is already present in the cell; this effect could be due to decreased delivery of ENaC to or enhanced removal of ENaC from the apical. The effect of Dex in CFBE41o
Ϫ parental and ⌬F508-overexpressing cells was mimicked by hydrocortisone, but not by aldosterone, and the whole cell abundance of the ENaC subunits was not significantly altered by Dex. The lack of effect of aldosterone was consistent with the only modestly increased expression of SGK1 that was similar in the parental, ⌬F508, and wt cells, which is consistent with similar Dex responsiveness among the three cell lines.
Regulation of ENaC trafficking by corrected ⌬F508-CFTR. Given the suggested importance of ENaC hyperactivity in the pathophysiology of the CF airway, effective correction of ⌬F508 function will likely require correction of both CFTRmediated Cl Ϫ transport and regulation of ENaC by CFTR. We therefore examined the influence of a prototypical strategy to correct ⌬F508 trafficking, treatment with 4PBA, on ENaC functional expression in Dex-treated CFBE41o Ϫ parental and ⌬F508 cells. Consistent with previous in vivo mouse (20) and human (51, 69) data, there was no significant change in the functional expression of endogenous ENaC on 4PBA treatment of CFBE41o
Ϫ parental cells (which have minimal endogenously expressed ⌬F508). In contrast, overexpression of ⌬F508 and 4PBA treatment synergistically increased endogenous ENaC functional expression. This synergistic increase in functional expression occurred without a change in the proportion of cleaved, higher P o vs. uncleaved, low P o ENaC as determined by response to apically applied trypsin, suggesting that it reflects increased total abundance of ENaC in the apical membrane. It also occurred without a change in the k app at which functional ENaC was retrieved from the apical membrane when new channel synthesis was inhibited. These data suggest that 4PBA and overexpressed ⌬F508-CFTR synergistically stimulate the delivery (or redelivery) of both cleaved and uncleaved ENaC to the apical membrane in CFBE41o Ϫ cells. These observations further suggest that 4PBA-mediated correction of ⌬F508 trafficking does not restore wt CFTR-like regulation of ENaC.
We also examined low temperature incubation as an alternate strategy to effect ⌬F508 correction that might allow ⌬F508 to regain wt CFTR-like regulation of ENaC. Low temperature incubation inhibited the induction of endogenous ENaC functional expression by Dex in both parental and ⌬F508-overexpressing CFBE41o Ϫ cells. This occurred without significant correction of CFTR function in the parental cells and with only modest correction of CFTR-mediated I sc in the ⌬F508-overexpressing CFBE41o Ϫ cells. Furthermore, like in the wt-expressing cells, application of trypsin to the apical surface of the temperature-corrected parental and ⌬F508-overexpressing cells did not cause an increase amiloride-sensitive I sc . It is attractive to interpret these data as suggesting that low temperature correction of even the minimal endogenous ⌬F508 present in CFBE41o
Ϫ parental cells could restore regulation of ENaC by ⌬F508. However, we feel that these data may more likely suggest that reduced temperature decreases the surface expression of endogenous ENaC at the apical membrane after
Dex in CFBE41o
Ϫ cells. Furthermore, since the ⌬F508-mediated currents of 4PBA-corrected ⌬F508-overexpressing cells (where ENaC functional expression is increased) are similar to those of the 27°C-corrected ⌬F508-overexpressing cells and greater than those of 27°C-corrected parental cells (where ENaC functional expression is minimal), the mechanism by which CFTR reduces ENaC functional expression cannot be solely dependent on or predicted by restoration of CFTRmediated Cl Ϫ transport. These data also suggest fundamental differences in the mechanisms by which 4PBA and reduced temperature correct ⌬F508 trafficking.
Summary. These data are consistent with wt CFTR expression preventing ENaC from residing in the apical membrane of CFBE41o Ϫ cells either in its active (cleaved) or inactive (uncleaved) form in response to Dex. These data therefore support the hypothesis that CFTR regulates endogenous ENaC apical surface expression in airway epithelial cells and that ⌬F508 lacks the ability to regulate endogenous ENaC surface expression even when its trafficking is corrected by 4PBA. These data also support that ENaC hyperactivity in CF airway epithelia does not solely result from excess cleavage/activation of ENaC after its delivery to the apical membrane due to an aberrant protease/anti-protease balance (40, 41) . Finally, these data suggest that the CFBE41o Ϫ ⌬F508-overexpressing cell, after Dex treatment to induce endogenous ENaC functional expression, is a useful and representative model of the CF airway epithelia for testing whether novel agents that correct ⌬F508 trafficking also allow appropriate regulation of ENaC function.
